Sachin Grover, lead of solutions vertical at Philips India, tells me about the company's innovations during India's COVID outbreak and how they've led to increased healthcare access in the
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<